1. Aaron, E., Blum, C., Seidman, D., Hoyt, M. J., Simone, J., Sullivan, M., & Smith, D. K. (2018). Optimizing delivery of HIV preexposure prophylaxis for women in the United States. AIDS Patient Care and STDs,32(1), 16–23.
2. Auerbach, J. D., Kinsky, S., Brown, G., & Charles, V. (2015). Knowledge, attitudes, and likelihood of pre-exposure prophylaxis (PrEP) use among US women at risk for acquiring HIV. AIDS Patient Care and STDs,29(2), 102–110.
3. Calabrese, S. K., Dovidio, J. F., Tekeste, M., Taggart, T., Galvao, R. W., Safon, C. B., … Kershaw, T. S. (2018). HIV pre-exposure prophylaxis stigma as a multidimensional barrier to uptake among women who attend Planned Parenthood. Journal of Acquired Immune Deficiency Syndromes,79(1), 46–53.
4. Centers for Disease Control and Prevention. (2014). Compendium of evidence-based interventions and best practices for HIV prevention. Retrieved February 24, 2020 from https://www.cdc.gov/hiv/research/interventionresearch/compendium/index.html.
5. Centers for Disease Control and Prevention. (2018a). HIV surveillance report, 2017 (Vol. 29). Retrieved February 24, 2020 from https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-report-2017-vol-29.pdf.